Clinical trial

Amyloid-β Clearance Mechanisms in Alzheimer's Disease

NCT05059158

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2021-06-01

PhaseN/A

Study timeline

Study start (actual)2021-06-01Date precision: day

Registry last updated2025-07-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Disease (AD)unresolved

Interventions

positron emission tomography (PET)RADIATION

Sponsors & collaborators

Ludwig-Maximilians - University of Munichlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05059158 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.